OFFICIAL LEGAL TITLE
Increasing Prescription Drug Competition Act
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 118_HR_4692.
Which chamber initiated this legislation?
This legislation was initiated in the House of Representatives.
When did the legislative process begin?
The process officially started on 2023-07-17.
What are the main provisions?
Key points include:
- Facilitates the market entry of cheaper generic drug alternatives.
- Limits pharmaceutical companies' ability to block competition using patents.
- Potential for lower drug prices and increased patient access.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Rep. Slotkin, Elissa [D-MI-7].
What is the latest detailed status?
The latest detailed status is: Referred to the Subcommittee on Health.
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.